Hohimer Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.04M	Sell	91,800 -10,000	-10%	-$239K	0.25%	127
2025 Q4	$2.72M	Hold	101,800	–	–	0.37%	86
2025 Q3	$2.17M	Sell	101,800 -16,083	-14%	-$380K	0.3%	106
2025 Q2	$2.54M	Sell	117,883 -42,759	-27%	-$795K	0.45%	72
2025 Q1	$2.67M	Sell	160,642 -913	-0.6%	-$16.6K	0.52%	68
2024 Q4	$2.96M	Buy	161,555 +2,422	+2%	+$39.1K	0.56%	65
2024 Q3	$2.45M	Hold	159,133	–	–	0.53%	78
2024 Q2	$2.59M	Buy	159,133 +142,000	+829%	+$2.29M	0.6%	71
2024 Q1	$317K	Hold	17,133	–	–	0.07%	197
2023 Q4	$536K	Hold	17,133	–	–	0.14%	150
2023 Q3	$357K	Sell	17,133 -750	-4%	-$20.4K	0.1%	160
2023 Q2	$428K	Sell	17,883 -2,382	-12%	-$52.9K	0.12%	153
2023 Q1	$381K	Hold	20,265	–	–	0.11%	157
2022 Q4	$323K	Buy	20,265 +4,250	+27%	+$66.4K	0.1%	135
2022 Q3	$262K	Sell	16,015 -500	-3%	-$8.1K	0.08%	153
2022 Q2	$233K	Hold	16,515	–	–	0.07%	166
2022 Q1	$400K	Hold	16,515	–	–	0.08%	156
2021 Q4	$385K	Hold	16,515	–	–	0.08%	153
2021 Q3	$274K	Buy	16,515 +1,980	+14%	+$38.2K	0.06%	157
2021 Q2	$355K	Buy	+14,535	New	+$328K	0.07%	155
2021 Q1	–	Sell	-3,865	Closed	-$207K	–	200
2020 Q4	$207K	Buy	+3,865	New	+$192K	0.05%	174
2020 Q3	–	Sell	-6,365	Closed	-$309K	–	181
2020 Q2	$309K	Buy	6,365 +2,500	+65%	+$120K	0.11%	161
2020 Q1	$201K	Sell	3,865 -9,000	-70%	-$371K	0.08%	170
2019 Q4	$550K	Buy	+12,865	New	+$560K	0.19%	162